On November 27, 2012, Illumina, Inc. (Nasdaq: ILMN) made a notification filing with the U.S. Department of Justice and the U.S. Federal Trade Commission under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with Illumina's proposed acquisition of Complete Genomics, Inc (Nasdaq: GNOM).